SUMO pathway dependent recruitment of cellular repressors to herpes simplex virus type 1 genomes

PLoS Pathogens

Volumn 7, Issue 7, 2011, Pages

  Cuchet Lourenço, Delphine ^a   Boutell, Chris ^a   Lukashchuk, Vera ^a   Grant, Kyle ^a   Sykes, Amanda ^a   Murray, Jill ^a   Orr, Anne ^a   Everett, Roger D ^a  

^a MRC UNIVERSITY OF GLASGOW CENTRE FOR VIRUS RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN HDAXX; PROTEIN SP100; REPRESSOR PROTEIN; SUMO 3 PROTEIN; SUMO PROTEIN; UNCLASSIFIED DRUG; AUTOANTIGEN; CELL NUCLEUS ANTIGEN; NUCLEAR DOT PROTEIN 52, HUMAN; NUCLEAR PROTEIN; PIAS2 PROTEIN, HUMAN; PML PROTEIN, HUMAN; PROTEIN INHIBITOR OF ACTIVATED STAT; SP100 PROTEIN, HUMAN; SUMO 1 PROTEIN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE; VIRUS DNA;

ARTICLE; CELL FUNCTION; CONTROLLED STUDY; EMBRYO; GENOME; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; MUTANT; NONHUMAN; PROMYELOCYTIC LEUKEMIA; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; WILD TYPE; CELL NUCLEUS; CELL STRAIN HEK293; GENETICS; HERPES SIMPLEX; METABOLISM; PROTEIN MOTIF; SIMPLEXVIRUS; SUMOYLATION; VIROLOGY; VIRUS GENOME;

HUMAN HERPESVIRUS 1;

AMINO ACID MOTIFS; ANTIGENS, NUCLEAR; AUTOANTIGENS; CELL NUCLEUS; DNA, VIRAL; GENOME, VIRAL; HEK293 CELLS; HERPES SIMPLEX; HUMANS; NUCLEAR PROTEINS; PROTEIN INHIBITORS OF ACTIVATED STAT; REPRESSOR PROTEINS; SIMPLEXVIRUS; SUMO-1 PROTEIN; SUMOYLATION; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES;

EID: 79960942804     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002123     Document Type: Article

References (53)

1. Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, et al. (2006) Fields virology Philadelphia Lippincott Williams and Wilkins.
2. Saffert RT, Kalejta RF, (2008) Promyelocytic leukemia-nuclear body proteins: herpesvirus enemies, accomplices, or both? Future Virology 3: 265-277.
3. Tavalai N, Stamminger T, (2008) New insights into the role of the subnuclear structure ND10 for viral infection. Biochim Biophys Acta 1783: 2207-2221.
4. Everett RD, Chelbi-Alix MK, (2007) PML and PML nuclear bodies: implications in antiviral defence. Biochimie 89: 819-830.
5. Everett RD, Rechter S, Papior P, Tavalai N, Stamminger T, et al. (2006) PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J Virol 80: 7995-8005.
6. Everett RD, Parada C, Gripon P, Sirma H, Orr A, (2008) Replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and Sp100. J Virol 82: 2661-2672.
7. Lukashchuk V, Orr A, Everett RD, (2010) Regulation of ICP0 null mutant HSV-1 infection by ND10 components ATRX and hDaxx. J Virol 84: 4026-4040.
8. Tavalai N, Papior P, Rechter S, Leis M, Stamminger T, (2006) Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections. J Virol 80: 8006-8018.
9. Cantrell SR, Bresnahan WA, (2006) Human cytomegalovirus (HCMV) UL82 gene product (pp71) relieves hDaxx-mediated repression of HCMV replication. J Virol 80: 6188-6191.
10. Lukashchuk V, McFarlane S, Everett RD, Preston CM, (2008) Human cytomegalovirus protein pp71 displaces the chromatin-associated factor ATRX from nuclear domain 10 at early stages of infection. J Virol 82: 12543-12554.
11. Preston CM, Nicholl MJ, (2006) Role of the cellular protein hDaxx in human cytomegalovirus immediate-early gene expression. J Gen Virol 87: 1113-1121.
12. Saffert RT, Kalejta RF, (2007) Human cytomegalovirus gene expression is silenced by Daxx-mediated intrinsic immune defense in model latent infections established in vitro. J Virol 81: 9109-9120.
13. Tavalai N, Papior P, Rechter S, Stamminger T, (2008) Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection. J Virol 82: 126-137.
14. Woodhall DL, Groves IJ, Reeves MB, Wilkinson G, Sinclair JH, (2006) Human Daxx-mediated repression of human cytomegalovirus gene expression correlates with a repressive chromatin structure around the major immediate early promoter. J Biol Chem 281: 37652-37660.
15. Everett RD, Freemont P, Saitoh H, Dasso M, Orr A, et al. (1998) The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms. J Virol 72: 6581-6591.
16. Parkinson J, Everett RD, (2000) Alphaherpesvirus proteins related to herpes simplex virus type 1 ICP0 affect cellular structures and proteins. J Virol 74: 10006-10017.
17. Chelbi-Alix MK, de The H, (1999) Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins. Oncogene 18: 935-941.
18. Everett RD, Murray J, (2005) ND10 components relocate to sites associated with herpes simplex virus type 1 nucleoprotein complexes during virus infection. J Virol 79: 5078-5089.
19. Everett RD, Sourvinos G, Leiper C, Clements JB, Orr A, (2004) Formation of nuclear foci of the herpes simplex virus type 1 regulatory protein ICP4 at early times of infection: localization, dynamics, recruitment of ICP27, and evidence for the de novo induction of ND10-like complexes. J Virol 78: 1903-1917.
20. Everett RD, Murray J, Orr A, Preston CM, (2007) Herpes simplex virus type 1 genomes are associated with ND10 nuclear substructures in quiescently infected human fibroblasts. J Virol 81: 10991-11004.
21. Everett RD, Parsy ML, Orr A, (2009) Analysis of the functions of herpes simplex virus type 1 regulatory protein ICP0 that are critical for lytic infection and derepression of quiescent viral genomes. J Virol 83: 4963-4977.
22. Song J, Durrin LK, Wilkinson TA, Krontiris TG, Chen Y, (2004) Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. Proc Natl Acad Sci U S A 101: 14373-14378.
23. Cuchet D, Sykes AK, Nicolas A, Orr A, Murray J, et al. (2011) PML isoforms I and II participate in PML-dependent restriction of HSV-1 replication. J Cell Sci 124: 280-291.
24. Jensen K, Shiels C, Freemont PS, (2001) PML protein isoforms and the RBCC/TRIM motif. Oncogene 20: 7223-7233.
25. Kastner P, Perez A, Lutz Y, Rochette-Egly C, Gaub MP, et al. (1992) Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins. Embo J 11: 629-642.
26. Shen TH, Lin HK, Scaglioni PP, Yung TM, Pandolfi PP, (2006) The mechanisms of PML-nuclear body formation. Mol Cell 24: 331-339.
27. Zhong S, Muller S, Ronchetti S, Freemont PS, Dejean A, et al. (2000) Role of SUMO-1-modified PML in nuclear body formation. Blood 95: 2748-2752.
28. Kamitani T, Kito K, Nguyen HP, Wada H, Fukuda-Kamitani T, et al. (1998) Identification of three major sentrinization sites in PML. J Biol Chem 273: 26675-26682.
29. Brand P, Lenser T, Hemmerich P, (2010) Assembly dynamics of PML nuclear bodies in living cells. PMC Biophys 3: 3.
30. Weidtkamp-Peters S, Lenser T, Negorev D, Gerstner N, Hofmann TG, et al. (2008) Dynamics of component exchange at PML nuclear bodies. J Cell Sci 121: 2731-2743.
31. Wiesmeijer K, Molenaar C, Bekeer IM, Tanke HJ, Dirks RW, (2002) Mobile foci of Sp100 do not contain PML: PML bodies are immobile but PML and Sp100 proteins are not. J Struct Biol 140: 180-188.
32. Dellaire G, Eskiw CH, Dehghani H, Ching RW, Bazett-Jones DP, (2006) Mitotic accumulations of PML protein contribute to the re-establishment of PML nuclear bodies in G1. J Cell Sci 119: 1034-1042.
33. Kim ET, Kim KK, Matunis MJ, Ahn JH, (2009) Enhanced SUMOylation of proteins containing a SUMO-interacting motif by SUMO-Ubc9 fusion. Biochem Biophys Res Commun 388: 41-45.
34. Sternsdorf T, Jensen K, Reich B, Will H, (1999) The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. J Biol Chem 274: 12555-12566.
35. Lin DY, Huang YS, Jeng JC, Kuo HY, Chang CC, et al. (2006) Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Mol Cell 24: 341-354.
36. Lee JM, Kang HJ, Lee HR, Choi CY, Jang WJ, et al. (2003) PIAS1 enhances SUMO-1 modification and the transactivation activity of the major immediate-early IE2 protein of human cytomegalovirus. FEBS Lett 555: 322-328.
37. Negorev DG, Vladimirova OV, Ivanov A, Rauscher F 3rd, Maul GG, (2006) Differential role of Sp100 isoforms in interferon-mediated repression of herpes simplex virus type 1 immediate-early protein expression. J Virol 80: 8019-8029.
38. Negorev DG, Vladimirova OV, Maul GG, (2009) Differential functions of interferon-upregulated Sp100 isoforms: herpes simplex virus type 1 promoter-based immediate-early gene suppression and PML protection from ICP0-mediated degradation. J Virol 83: 5168-5180.
39. Wilcox KW, Sheriff S, Isaac A, Taylor JL, (2005) SP100B is a repressor of gene expression. J Cell Biochem 95: 352-365.
40. Fu J, Xiong Y, Xu Y, Cheng G, Tang H, (2011) MDA5 is SUMOylated by PIAS2beta in the upregulation of type I interferon signaling. Mol Immunol 48: 415-422.
41. Wanzel M, Kleine-Kohlbrecher D, Herold S, Hock A, Berns K, et al. (2005) Akt and 14-3-3eta regulate Miz1 to control cell-cycle arrest after DNA damage. Nat Cell Biol 7: 30-41.
42. Everett RD, (2006) Interactions between DNA viruses, ND10 and the DNA damage response. Cell Microbiol 8: 365-374.
43. Maul GG, (1998) Nuclear domain 10, the site of DNA virus transcription and replication. Bioessays 20: 660-667.
44. Sourvinos G, Tavalai N, Berndt A, Spandidos DA, Stamminger T, (2007) Recruitment of human cytomegalovirus immediate-early 2 protein onto parental viral genomes in association with ND10 in live-infected cells. J Virol 81: 10123-10136.
45. Galanty Y, Belotserkovskaya R, Coates J, Polo S, Miller KM, et al. (2009) Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks. Nature 462: 935-939.
46. Morris JR, Boutell C, Keppler M, Densham R, Weekes D, et al. (2009) The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress. Nature 462: 886-890.
47. Lilley CE, Chaurushiya MS, Boutell C, Landry S, Suh J, et al. (2010) A viral E3 ligase targets RNF8 and RNF168 to control histone ubiquitination and DNA damage responses. EMBO J 29: 943-955.
48. Hay RT, (2005) SUMO: a history of modification. Mol Cell 18: 1-12.
49. Ribet D, Hamon M, Gouin E, Nahori MA, Impens F, et al. (2010) Listeria monocytogenes impairs SUMOylation for efficient infection. Nature 464: 1192-1195.
50. Gripon P, Rumin S, Urban S, Le Seyec J, Glaise D, et al. (2002) Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci U S A 99: 15655-15660.
51. Stow ND, Stow EC, (1986) Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110. J Gen Virol 67: 2571-2585.
52. Stuurman N, de Graaf A, Floore A, Josso A, Humbel B, et al. (1992) A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies. J Cell Sci 101: 773-784.
53. Sternsdorf T, Jensen K, Will H, (1997) Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J Cell Biol 139: 1621-1634.